Best Sustainability Tech Companies in Shanghai, China
The 58 best Sustainability Tech companies in Shanghai, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: JBD.
Our analysis of 293 Sustainability Tech companies
$38.4b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Sustainability Tech companies in Shanghai
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | 6dianban Smart light tool which is focused on alarms | — | — | — | Deng Kai Founder & CEO | — | — | — |
| 2 | acrel Acrel develops, manufactures, and sells power meters. | — | — | 763 | — | Windows ServerMediaElement.jsVideoJS+7 | Top 50M | 1 launch · 1 award |
| 3 | Adenergy IoT-based platform for energy management of smart buildings | — | — | — | Fulvio Bartolucci Co-Founder | — | — | — |
| 4 | AiSunrice AI-driven platform offering energy monitoring solutions for commercial applications | — | — | — | Rex Su Founder | — | — | — |
| 5 | Aries Pro Provider of data analytics and cloud-based solutions for utility industries | — | — | 18 | Shivani Sangari CEO | Windows ServerFacebook LoginYouTube+10 | Top 50M | — |
| 6 | BBM Developer of AAV-based gene therapies for multiple diseases | — | — | 270 | Jane Zheng Co-Founder | — | — | — |
| 7 | BEE Provider of green building consulting services | — | — | 27 | — | WordPressMySQLPHP+12 | Top 10M | — |
| 8 | Bituo Technik Provider of electrical measurement and residual current detection solutions | — | — | — | Xiang Han Co-Founder | WordPressBetterDocsMySQL+24 | Top 5M | — |
Top 12 Sustainability Tech companies in Shanghai
#1
Series B · Pudong, Shanghai · founded 2015$140.4Mraised▾
Manufacturer of micro-LED displays. It develops active-matrix inorganic microLED display chips and panels, which have wavelengths ranging from UV to IR. It also offers control circuit boards to drive those display chips. It also offers custom displays with custom wavelengths, resolution, pixel pitch, and brightness.
- Oct 2025Series B$140.4M
- Jun 2024Series A—
- Jun 2023Series A—
- Aug 2022Series A—
#2
Series B · Shanghai, Shanghai · founded 2021$14.1Mraised▾
Developer of gene editing and LNP delivery platforms for therapeutics. It focuses on creating novel tools for genome editing using metagenomics data. It develops in vivo gene-editing medicines for genetic, metabolic, cancer, and cardiovascular diseases. It is researching treatments for diseases such as familial hypercholesterolemia and hereditary transthyretin amyloidosis.
- Sep 2025Series B$45M
- Nov 2023Series A$14.1M
- Feb 2022Angel—
- Series A—
#3
Series A · Shanghai, Shanghai · founded 2021$103.8Mraised▾
Developer of oligonucleotide therapeutics for various diseases. The company specializes in siRNA drug discovery and development, utilizing siRNA platform technology and RADS to offer a pipeline of therapeutics for cardiovascular, rare diseases, CNS diseases, viral hepatitis, metabolic diseases, and more.
- Nov 2023Series A$41M
- Mar 2022Seed$62.8M
#4
Series B · Shanghai, Shanghai · founded 2018$56Mraised▾
Developer of monoclonal antibodies for the treatment of multiple diseases. The company offers a PRL receptor antibody that blocks the PRL receptor-mediated pathway for the treatment of male and female pattern hair loss, endometriosis, and other chronic diseases.
- Feb 2024Series B—
- May 2021Series B$56M
- Apr 2019Series A—
#5
Series C · Shanghai, Shanghai · founded 2015 · 118 employees$83Mraised▾
Drug Farm is a developer of a novel treatment for metabolic diseases. The company uses AI-directed medicinal chemistry to develop small molecule drugs against new targets. The product pipeline includes DF-006 for hepatitis-B, DF-007 for fatty liver disease, DF-008 for Cancer, and DF-003 for rare blindness.
- May 2023Series C$27M
- Feb 2021Series A$56M
#6
Series A · Shanghai, Shanghai · founded 2016 · 11 employees$83.9Mraised▾
Provides drone data management solutions. It offers drone data acquisition flight services and a cloud-based data analysis and viewing software solution. It also offers IT consulting and data migration services to enterprise clients. It also provides drone-based wind turbine inspection and monitoring solutions.
- Mar 2021Series A$30.9M
- Jan 2020Series A$10M
- Aug 2019Series A$22M
- Aug 2018Series A$11M
#7
Series A · Shanghai, Shanghai · founded 2017$49.1Mraised▾
Zhimeng Biopharma is a developer of drugs for the treatment of chronic hepatitis B (CHB) and related liver diseases. The company has discovered a novel series of pyrazole compounds as HBV nucleocapsid formation inhibitors (represented by CB-001). CB-001 is structurally distinct from the current class I (heteroaryl dihydropyridines, e.g., BAY-41-4109 and GLS4) and class II (phenylpropenamides and sulfamoyl benzamides, e.g., AT-130) HBV core protein allosteric modulators (CpAMs). The company also has active programs for neurologic disorders that are ready for co-development.
- Nov 2020Series A$34.8M
- Nov 2019Seed$14.3M
- Seed—
#8
Acquired · Shanghai, Shanghai · founded 2006 · 46511 employees$35Mraised▾
Manufacturer of solar modules. It uses Bifacial module with transparent backsheet technology and half-cell module technology for manufacturing solar modules.
- Oct 2020Post IPO$461.6M
- May 2019Post IPO$85M
- Feb 2019Post IPO$15.2M
- Oct 2008Series B$35M
#9
Public · Shanghai, Shanghai · founded 2012 · 2772 employees$31.5Mraised▾
Provider of antibody-based therapeutics for multiple diseases. The company's drug candidates include anti-PD-1 monoclonal antibodies, PCSK9 monoclonal antibodies, anti-BLyS monoclonal antibodies, and others for the treatment of cancer, metabolic, neurology, immunology, and infectious diseases.
- Feb 2018Post IPO$31.5M
#10
Series A · Shanghai, Shanghai · founded 2018$10.6Mraised▾
Provider of a gene-editing platform for the treatment of genetic diseases. It uses the unique mRNA delivery technology to achieve safe and efficient delivery of gene-editing tools such as CRISPR. In addition, BD-mRNA technology has important application prospects in the fields of tumor immunity and regenerative medicine. It also uses the fourth-generation lentiviral vector platform for all types of cells. It has developed antiviral eyedrops and others.
- Apr 2021Series A$9.2M
- Mar 2020Seed$1.4M
- Jun 2019Seed—
#11
Series A · Shanghai, Shanghai · founded 2013$8.8Mraised▾
PowerBee provides IoT solutions for energy management. Products include power communication chip, smart plugs, smart meters. Also, provides IoT applications such as power management system, lighting control system, temperature control system. Claims to have shipped over 100,000 smart meters to 10 cities mainly to the apartment market.
- Jul 2018Series A$8.8M
- Jul 2017Angel—
#12
Series A · Pudong, Shanghai · founded 2013 · 8 employees$3.6Mraised▾
Provider of a cloud-based augmented intelligence software platform. The company's vertical industrial application leverages artificial intelligence to develop infrastructure-level smart services and smart devices that help in achieving automatic conversion from raw data to meaningful business-related conclusions by natural language, enabling manufacturers across different industries to increase their production efficiency.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Sustainability Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Climate Adaptation in Shanghai is moving
A read on the academic research around Climate Adaptation in Shanghai — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 63 papers.
Shanghai University and Jiao Tong University lead flood risk and sustainable finance research across 63 papers, with optimistic advancement framing dominating recent post-2020 output.
- Shanghai University13
- Shanghai Jiao Tong University10
- Shanghai University of Finance and Economics7
- Shanghai Normal University6
- Shanghai Business School5
- Climate change6
- Index (typography)3
- Flood myth3
- Flooding (psychology)3
- Resilience (materials science)2
- Flood myth1→6
- China1→4
- Flooding (psychology)1→3
- Flood myth1→5
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.